Study of ENMD-2076 in Patients With Relapsed or Refractory Hematological Malignancies
Clinical trial NCT00904787 · COMPLETED
Trial details
- NCT number
- NCT00904787
- Sponsor
- CASI pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2010-12-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.